CereGate

medical devices

About

CereGate is a German neurotechnology company founded in 2019 and based in Hamburg. The company specializes in developing a Computer-Brain Interface (CBI) platform that facilitates direct communication with the human brain. Their technology is compatible with existing neuromodulation implants, such as Deep Brain Stimulation (DBS) and Spinal Cord Stimulation (SCS) devices, and is designed to enhance the treatment of neurological and psychiatric disorders. Currently, CereGate focuses on improving gait and balance symptoms in Parkinson’s disease patients and addressing vestibular disorders. CereGate’s software platform utilizes advanced neuromodulation technology to modulate neural activity, aiming to restore human senses and improve patients' quality of life. The company has conducted over 85 successful patient trials, demonstrating the effectiveness of their solutions. They are pursuing FDA trials and Breakthrough Device status, highlighting their commitment to innovation. CereGate's technology is adaptable and scalable, making it suitable for various medical conditions and appealing for partnerships in the medtech industry.

Technologies

GmailGoogle AppsApacheMobile FriendlyRemote

Keywords

medical equipment manufacturingbrain implantsneural interfacesneural interface for movement disorderscomputer-brain interfaceservicesneurodiagnosticsbrain signal enhancementspinal cord stimulator as cbibrain-computer interfaceneural interface softwareneurostimulation for sensory restorationnon-invasive neural interfacesminimally invasiveneurorehabilitationclinical validationneural communicationspinal cord stimulatormedical equipment and supplies manufacturingneuromodulationb2bneurotechnologybrain signal decodingbrain-computer communicationmachine learningneuroprostheticsmedical devicesbrain healthneural circuit modulationneuroscience

Location

Munich, Bavaria, Germany, 80539

Related Companies

Companies in the same industry